Histiocytic sarcoma of the parotid gland region

Pathology International

Volumn 61, Issue 6, 2011, Pages 373-376

  Akiba, Jun ^a   Harada, Hiroshi ^c   Kawahara, Akihiko ^a   Arakawa, Fumiko ^a   Mihashi, Hiroyuki ^b   Mihashi, Ryouta ^b   Ohshima, Koichi ^a   Yano, Hirohisa ^a  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAKAI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Histiocytic sarcoma; Immunohistochemical stain; Parotid gland

Indexed keywords

CD163 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; LANGERIN; PROTEIN S 100; T6 ANTIGEN;

ADULT; ARTICLE; ASPIRATION CYTOLOGY; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; DEATH; DISEASE COURSE; FEMALE; GIANT CELL; HISTIOCYTIC SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAROTID GLAND CANCER; PAROTIDECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CELL;

ANTIGENS, CD; CHEMOTHERAPY, ADJUVANT; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HISTIOCYTIC SARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; MIDDLE AGED; PAROTID NEOPLASMS; PAROTID REGION; POLYMERASE CHAIN REACTION; RADIOTHERAPY, ADJUVANT; TIME FACTORS;

EID: 79957563246     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02671.x     Document Type: Article

References (16)

1. Hornick JL, Jaffe ES, Fletcher CMD. Extranodal histiocytic sarcoma: Clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 2004; 28: 1133-44.
2. Copie-Bergman C, Wotherspoon AC, Norton AJ, Diss TC, Isaacson PG. True histiocytic lymphoma: A morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol 1998; 22: 1386-92.
3. Grogan TM, Pileri SA, Chen JKC, Weiss LM, Fletcher CMD. Histiocytic and dendritic cell neoplasms. In: Swerdlow SH, Campo E, Harris NL etal, eds. WHO Classification of Tumour of Haematopoietic and Lymphoid Tissues. Lyon: IARC, 2008; 353-67.
4. Akiba J, Nakane T, Arakawa F, Ohshima K, Yano H. Collision of EBV-associated gastric carcinoma and primary gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the remnant stomach. Pathol Int 2010; 60: 102-6.
5. Hanson CA, Jaszcz W, Kersey JH etal. True histiocytic lymphoma: Histopathologic, immunophenotypic and genotypic analysis. Br J Haematol 1989; 73: 187-98.
6. Kamel OW, Gocke CD, Kell DL, Cleary ML, Warnke RA. True histiocytic lymphoma: A study of 12 cases based on current definition. Leuk Lymphoma 1995; 18: 81-6.
7. Pileri SA, Grogan TM, Harris NL etal. Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1-29.
8. Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS. Histiocytic sarcoma: A study of five cases including the histiocyte marker CD163. Mod Pathol 2005; 18: 693-704.
9. Chen W, Lau SK, Fong D etal. High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas. Am J Surg Pathol 2009; 33: 863-73.
10. Chan JK, Tsang WY, Ng CS. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease. Am J Surg Pathol 1994; 18: 517-25.
11. McKenney JK, Weiss SW, Folpe AL. CD31 expression in intratumoral macrophages: A potential diagnostic pitfall. Am J Surg Pathol 2001; 25: 1167-73.
12. Ralfkiaer E, Delsol G, O'Connor NT etal. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol 1990; 160: 9-17.
13. Feldman AL, Arber DA, Pittaluga S etal. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: Evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008; 111: 5433-9.
14. Anderson LJ, Longnecker R. Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo. Blood 2009; 113: 108-16.
15. Gliddon DR, Hope JC, Brooke GP, Howard CJ. DEC-205 expression on migrating dendritic cells in afferent lympho. Immunology 2004; 111: 262-72.
16. Alvaro T, Bosch R, Salvadó MT, Piris MA. True histiocytic lymphoma of the stomach associated with low-grade B-cell mucosa-associated lymphoid tissue (MALT)-type lymphoma. Am J Surg Pathol 1996; 20: 1406-11.